DaVita launches FDA advisory committee prep service

Related tags Clinical research Food and drug administration Pharmaceutical drug Davita clinical research

DaVita Clinical Research will help sponsors prepare for US FDA advisory committee meetings through a new contract offering introduced this week.

The idea is to lead pharmaceutical firms through the process of creating, preparing and rehearsing presentations to agency committees, which are critical steps in its drug approval process.

Mahesh Krishnan, DCR’s VP of clinical research, said: "Professional communicators move pharmaceutical teams toward their goal in a way no other function can -- a lesson I learned from my own experience preparing for an advisory committee meeting."

The new offering brings to an end a busy month for Davita, which began with the launch of a contract biorepository service​ and followed with the expansion of the firm’s drug discovery laboratory in Minneapolis.

Related news

Related products

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Clear Guidelines for IND/CTA

Clear Guidelines for IND/CTA

Altasciences | 24-Feb-2022 | Technical / White Paper

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...

Related suppliers

Follow us


View more